Business Context and Reporting Period
Company: MiMedx Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 30, 2022
Reporting Period: Event date of November 30, 2022
This filing discloses the Company's participation in the Piper Sandler 34th Annual Healthcare Conference. Management attendees included K. Todd Newton (Interim CEO), Peter M. Carlson (CFO), and Matthew Notarianni (Head of Investor Relations).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of a conference presentation rather than a financial results announcement.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The primary disclosure is the furnishing of presentation materials (Exhibit 99.1) related to the conference.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a slide presentation (Exhibit 99.1) made available at the conference. However, the text of the 8-K explicitly states that the information in this report and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Risks and Contingencies: No specific risks or contingencies are outlined in the body of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Slide Presentation dated November 30, 2022) for detailed financial data and strategic outlook, as the 8-K text only references these materials.
- Note that the presentation materials are not legally "filed" under Section 18 of the Exchange Act, meaning they may not carry the same liability protections as formal financial statements.
- Verify the current status of K. Todd Newton as Interim CEO and Peter M. Carlson as CFO.